Terumo Corp. (TYO:4543) said today it inked a strategic partnership deal with CytoSorbents to commercialize its CytoSorb blood purification adsorber for cardiac surgery applications. New Jersey-based CytoSorbents said its CytoSorb adsorber is designed to reduce excessive levels of inflammatory mediators in cardiac surgery and critically ill patients. “Our collaboration with CytoSorbents enables us to offer […]
CytoSorbents (OTC:CTSO) said today it’s dropping its pursuit of the FDA’s fast-track Expedited Access Pathway for its CytoSorb for treating sepsis. The decision came after meeting with the FDA’sCenter for Devices and Radiological Health and Center for Drug Evaluation and Research in which the company came to the conclusion that “there would be no significant time […]
The FDA approved two cardiac ablation catheters made by St. Jude Medical Inc. (NYSE:STJ).
The devices are designed to treat cardiac arrhythmias through the targeted scaring of heart tissue to block abnormal electrical signals that would contribute to irregular heart beats.